Fig. 1: Antiproliferative effect of Ropeg in MPN-derived human cell lines.
From: Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo
A and B The JAK2V617F positive UKE1 and HEL cell lines. C and D The UT-7 cell line expressing a wild type or a mutant form of JAK2. Cells were treated with the indicated drugs and the living cells were counted every day. Results are expressed as the fold increase compared to day 0
